Postbiotic Supplements Market Industry Analysis 2020-2036
Market Coverage: The report provides 15 years of data, with 5 years of historical (2020-2025) and 10
years of forecast data (2026-2035), including CAGR, YoY trends, and segment analysis.
Segmentation Coverage:
- Compound Type: Short-chain Fatty Acids (SCFAs), Lipopolysaccharides, Muramyl
Dipeptide (MDP), Indole Derivatives, other Compounds - Form: Capsules and Tablets, Soft-gels and Chews, Powders and Granules, Liquids
Sales Channel: Online Retailers/Pharmacies, Pharmacy Chains & Drugstores,
Supermarkets/Hypermarkets, Health and Beauty Stores, other Channels
In-depth Region-wise Analysis: Covers a detailed analysis of 5 major regions and 25+ countries, with
granular analysis by all segments/sub-segments
Pricing Benchmarking: Analyzes average pricing analysis by product types and factors influencing
pricing dynamics
Market Attractiveness Outlook: Identifies investment opportunities by evaluating market
attractiveness across key segments, regions and top countries
Industry Assessment Frameworks: The report assesses key frameworks like Porter’s 5 Forces,
PESTEL analysis, and regulatory implications to understand external market impacts
Competition Assessment: The report provides a market share analysis of top vendors and detailed
vendor profiles covering, product offering, SWOT analysis, and business growth strategies
Report Coverage & Deliverables
- Market Trends And Dynamics
- Competitve Benchmarking
- Historical data and forecasts
- Value/Volume analysis
- Company revenue shares and key strategies
- Regional opportunities
Investigates the market expansion, major participants, and consumer uptake of postbiotic supplements as cutting-edge goods for improving immunity and intestinal health.
1. Executive Summary
1.1. Overall Market Growth Outlook
1.2. Market Taxonomy
1.3. Analyst Point of View
2. Market Dynamics & Trends
2.1. Market Drivers
2.2. Market Challenges
2.3. Key Trends
3. Pricing Analysis
3.1. Average Pricing Analysis. By Product Type
3.2. Country-wise Pricing Benchmarking
3.3. Factors Impacting Product Prices
4. Industry Benchmarking & Frameworks
4.1. PESTLE Analysis and Impact on the Industry
4.2. Porter’s Five Force Model Assessment
4.3. Regulatory Landscape and Impact on the Market
5. Global Postbiotic Supplements Market Size Analysis, By
Value ($ Mn)
5.1. Historic Market Size (US$ Mn) Analysis, 2020-2024
5.2. Forecasted Market Size (US$ Mn) Analysis, 2025-
2035
5.3. CAGR % Growth Outlook
6. Global Postbiotic Supplements Market Size Analysis
(2020-2035), Value ($ Mn), By Compound Type
6.1. Short-chain Fatty Acids (SCFAs)
6.2. Lipopolysaccharides
6.3. Muramyl Dipeptide (MDP)
6.4. Indole Derivatives
6.5. Other Compounds
7. Global Postbiotic Supplements Market Industry
Analysis (2020-2035), Value ($ Mn), By Form
7.1. Capsules and Tablets
7.2. Soft-gels and Chews
7.3. Powders and Granules
7.4. Liquids
8. Global Postbiotic Supplements Market Industry
Analysis (2020-2035), Value ($ Mn), By Sales Channel
8.1. Online Retailers/Pharmacies
8.2. Pharmacy Chains & Drugstores
8.3. Supermarkets/Hypermarkets
8.4. Health and Beauty Stores
8.5. Other Channels
9. Global Postbiotic Supplements Market Industry
Analysis (2020-2035), Value ($ Mn), By Region
9.1. North America
9.2. Latin America
9.3. Europe
9.4. Asia Pacific
9.5. Middle East & Africa
10. North America Postbiotic Supplements Market
Industry Analysis (2020-2035)
10.1. By Compound Type
10.2. By Form
10.3. By Sales Channel
10.4. By Country
10.4.1. US
10.4.2. Canada
11. Latin America Postbiotic Supplements Market Industry
Analysis (2020-2035)
11.1. By Compound Type
11.2. By Form
11.3. By Sales Channel
11.4. By Country
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Chile
11.4.4. Rest of Latin America
12. Europe Postbiotic Supplements Market Industry
Analysis (2020-2035)
12.1. By Compound Type
12.2. By Form
12.3. By Sales Channel
12.4. By Country
12.4.1. UK
12.4.2. Germany
12.4.3. France
12.4.4. Spain
12.4.5. Italy
12.4.6. Nordics
12.4.7. Benelux
12.4.8. Russia
12.4.9. Poland
12.4.10. Rest of Europe
13. Asia Pacific Postbiotic Supplements Market Industry
Analysis (2020-2035)
13.1. By Compound Type
13.2. By Form
13.3. By Sales Channel
13.4. By Country
13.4.1. China
13.4.2. Japan
13.4.3. South Korea
13.4.4. India
13.4.5. ASEAN
13.4.6. Australia & New Zealand
13.4.7. Rest of Asia Pacific
14. Middle East & Africa Postbiotic Supplements Market
Industry Analysis (2020-2035)
14.1. By Compound Type
14.2. By Form
14.3. By Sales Channel
14.4. By Country
14.4.1. Saudi Arabia
14.4.2. UAE
14.4.3. Turkey
14.4.4. South Africa
14.4.5. North Africa
14.4.6. Rest of MEA
15. Country
-wise Market Analysis
15.1.US Market Analysis
15.1.1. By Compound Type
15.1.2. By Form
15.1.3. By Sales Channel
15.2. Canada Market Analysis
15.2.1. By Compound Type
15.2.2. By Form
15.2.3. By Sales Channel
15.3. Mexico Market Analysis
15.3.1. By Compound Type
15.3.2. By Form
15.3.3. By Sales Channel
15.4. Brazil Market Analysis
15.4.1. By Compound Type
15.4.2. By Form
15.4.3. By Sales Channel
15.5. Chile Market Analysis
15.5.1. By Compound Type
15.5.2. By Form
15.5.3. By Sales Channel
15.6.UK Market Analysis
15.6.1. By Compound Type
15.6.2. By Form
15.6.3. By Sales Channel
15.7.Germany Market Analysis
15.7.1. By Compound Type
15.7.2. By Form
15.7.3. By Sales Channel
15.8. France Market Analysis
15.8.1. By Compound Type
15.8.2. By Form
15.8.3. By Sales Channel
15.9. Spain Market Analysis
15.9.1. By Compound Type
15.9.2. By Form
15.9.3. By Sales Channel
15.10. Italy Market Analysis
15.10.1. By Compound Type
15.10.2. By Form
15.10.3. By Sales Channel
15.11. Nordics Market Analysis
15.11.1. By Compound Type
15.11.2. By Form
15.11.3. By Sales Channel
15.12. Benelux Market Analysis
15.12.1. By Compound Type
15.12.2. By Form
15.12.3. By Sales Channel
15.13. Russia Market Analysis
15.13.1. By Compound Type
15.13.2. By Form
15.13.3. By Sales Channel
15.14. Poland Market Analysis
15.14.1. By Compound Type
15.14.2. By Form
15.14.3. By Sales Channel
15.15. China Market Analysis
15.15.1. By Compound Type
15.15.2. By Form
15.15.3. By Sales Channel
15.16. Japan Market Analysis
15.16.1. By Compound Type
15.16.2. By Form
15.16.3. By Sales Channel
15.17. South Korea Market Analysis
15.17.1. By Compound Type
15.17.2. By Form
15.17.3. By Sales Channel
15.18. India Market Analysis
15.18.1. By Compound Type
15.18.2. By Form
15.18.3. By Sales Channel
15.19. ASEAN Market Analysis
15.19.1. By Compound Type
15.19.2. By Form
15.19.3. By Sales Channel
15.20. Australia & NZ Market Analysis
15.20.1. By Compound Type
15.20.2. By Form
15.20.3. By Sales Channel
15.21. Saudi Arabia Market Analysis
15.21.1. By Compound Type
15.21.2. By Form
15.21.3. By Sales Channel
15.22. UAE Market Analysis
15.22.1. By Compound Type
15.22.2. By Form
15.22.3. By Sales Channel
15.23. Turkey Market Analysis
15.23.1. By Compound Type
15.23.2. By Form
15.23.3. By Sales Channel
15.24. South Africa Market Analysis
15.24.1. By Compound Type
15.24.2. By Form
15.24.3. By Sales Channel
15.25. North Africa Market Analysis
15.25.1. By Compound Type
15.25.2. By Form
15.25.3. By Sales Channel
16. Brand Landscape Assessment
16.1. Brand Shares Analysis of Key Vendors
16.2.Detailed Vendor Profiles
16.2.1. Company Overview
16.2.2. Product Portfolio
16.2.3. SWOT Analysis
16.2.4. Business Strategies
16.2.5. Recent Industry Developments
16.3. Major Postbiotic Supplements Brands
16.3.1. Dr. Emil Nutrition
16.3.2. Designs for Health
16.3.3. MaryRuth Organics
16.3.4. Essential Formulas Inc. (Dr. Ohhira’s
Probiotics)
16.3.5. Beekeeper’s Naturals
16.3.6. Probulin
16.3.7. Bio Complete 3 (Gundry MD)
16.3.8. For The Biome
16.3.9. Gaia Herbs
16.3.10. Primal Harvest
16.3.11. PoZibio®
16.3.12. ResBiotic
16.3.13. Nestlé Health Science
16.3.14. ADM (Archer Daniels Midland Company)
16.3.15. DuPont Nutrition & Biosciences
16.3.16. Sabinsa Corporation
16.3.17. Lallemand Inc.
16.3.18. Lesaffre Group
16.3.19. Probiotical S.p.A.
16.3.20. MRM Nutrition
17. Research Methodology